Which patients should receive the herpes zoster vaccine?

被引：1
作者：
Short, Mandy D. [1 ]
Fergus, Christina [1 ]
机构：
[1] Blue Cross Blue Shield Arizona, Phoenix, AZ 85062 USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2019年 / 32卷 / 09期
关键词：
herpes zoster; vaccine; Shingrix; Advisory Committee on Immunization Practices; shingles; varicella; SUBUNIT VACCINE; TERM PERSISTENCE; OPEN-LABEL; PHASE-III; SAFETY; IMMUNOGENICITY; EFFICACY; AGE;
D O I：
10.1097/01.JAA.0000578788.69674.2b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The recombinant adjuvanted zoster vaccine (RZV, trade name Shingrix) is preferentially recommended by the Advisory Committee on Immunization Practices to prevent herpes zoster and related complications in immunocompetent adults age 50 years and older. This article reviews efficacy and safety of the vaccine, its use in special populations, and how to prevent administration errors to answer the question "Which patients should receive the herpes zoster vaccine?"
引用
收藏
页码：18 / 20
页数：3
相关论文
共 18 条
  • [1] [Anonymous], 2006, ZOST PRESCR INF, P2006
  • [2] Centers for Disease Control and Prevention, Vaccination
  • [3] Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
    Cunningham, A. L.
    Lal, H.
    Kovac, M.
    Chlibek, R.
    Hwang, S. -J.
    Diez-Domingo, J.
    Godeaux, O.
    Levin, M. J.
    McElhaney, J. E.
    Puig-Barbera, J.
    Abeele, C. Vanden
    Vesikari, T.
    Watanabe, D.
    Zahaf, T.
    Ahonen, A.
    Athan, E.
    Barba-Gomez, J. F.
    Campora, L.
    de Looze, F.
    Downey, H. J.
    Ghesquiere, W.
    Gorfinkel, I.
    Korhonen, T.
    Leung, E.
    McNeil, S. A.
    Oostvogels, L.
    Rombo, L.
    Smetana, J.
    Weckx, L.
    Yeo, W.
    Heineman, T. C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (11) : 1019 - 1032
  • [4] Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
    Dooling, Kathleen L.
    Guo, Angela
    Patel, Manisha
    Lee, Grace M.
    Moore, Kelly
    Belongia, Edward A.
    Harpaz, Rafael
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2018, 67 (03): : 103 - 108
  • [5] Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
    Godeaux, Olivier
    Kovac, Martina
    Shu, Daniel
    Grupping, Katrijn
    Campora, Laura
    Douha, Martine
    Heineman, Thomas C.
    Lal, Himal
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (05) : 1051 - 1058
  • [6] Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
    Grupping, Katrijn
    Campora, Laura
    Douha, Martine
    Heineman, Thomas C.
    Klein, Nicola P.
    Lal, Himal
    Peterson, James
    Vastiau, Ilse
    Oostvogels, Lidia
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (11) : 1343 - 1351
  • [7] Kroger A., BEST PRACTICES GUIDA
  • [8] Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study
    Lal, Himal
    Poder, Airi
    Campora, Laura
    Geeraerts, Brecht
    Oostvogels, Lidia
    Abeele, Carline Vanden
    Heineman, Thomas C.
    [J]. VACCINE, 2018, 36 (01) : 148 - 154
  • [9] Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
    Lal, Himal
    Cunningham, Anthony L.
    Godeaux, Olivier
    Chlibek, Roman
    Diez-Domingo, Javier
    Hwang, Shinn-Jang
    Levin, Myron J.
    McElhaney, Janet E.
    Poder, Airi
    Puig-Barbera, Joan
    Vesikari, Timo
    Watanabe, Daisuke
    Weckx, Lily
    Zahaf, Toufik
    Heineman, Thomas C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (22) : 2087 - 2096
  • [10] Long-term Persistence of Zoster Vaccine Efficacy
    Morrison, Vicki A.
    Johnson, Gary R.
    Schmader, Kenneth E.
    Levin, Myron J.
    Zhang, Jane H.
    Looney, David J.
    Betts, Robert
    Gelb, Larry
    Guatelli, John C.
    Harbecke, Ruth
    Pachucki, Connie
    Keay, Susan
    Menzies, Barbara
    Griffin, Marie R.
    Kauffman, Carol A.
    Marques, Adriana
    Toney, John
    Boardman, Kathy
    Su, Shu-Chih
    Li, Xiaoming
    Chan, Ivan S. F.
    Parrino, Janie
    Annunziato, Paula
    Oxman, Michael N.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (06) : 900 - 909
12